Treatment of acute heart failure in the emergency department

References

• Ramirez A, Abelmann WH. Cardiac decompensation. N. Engl. J. Med. 290, 499–501 (1974).
   PubMed Web of Science ®Google Scholar
• Pang PS, Komajda M, Gheorghiade M. The current and future management of acute heart failure syndromes. Eur. Heart J. 31(7), 784–793 (2010).
   PubMed Web of Science ®Google Scholar
• Hauptman PJ, Schnitzler MA, Swindle J, Burroughs TE. Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure. JAMA 296(15), 1877–1884 (2006).
   PubMed Web of Science ®Google Scholar
• Hunt SA, Abraham WT, Chin MH et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults a report of the american college of cardiology foundation/american heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation. J. Am. Coll. Cardiol. 53(15), e1–e90 (2009).
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Adamopoulos S, Anker SD et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology. developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 33(14), 1787–1847 (2012).
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Zannad F, Sopko G et al. Acute heart failure syndromes: current state and framework for future research. Circulation 112(25), 3958–3968 (2005).
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffarian D, Roger VL et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation 127(1), e6–e245 (2013).
   PubMed Web of Science ®Google Scholar
• Adams KF, Jr., Fonarow GC, Emerman CL et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am. Heart J. 149(2), 209–216 (2005).
   PubMed Web of Science ®Google Scholar
• Fonarow GC. Acute decompensated heart failure: challenges and opportunities. Rev. Cardiovasc. Med. 8( Suppl. 5), S3–S12 (2007).
   PubMedGoogle Scholar
• Gheorghiade M, Abraham WT, Albert NM et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296(18), 2217–2226 (2006).
   PubMed Web of Science ®Google Scholar
• Fonarow GC, Stough WG, Abraham WT et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J. Am. Coll. Cardiol. 50(8), 768–777 (2007).
   PubMed Web of Science ®Google Scholar
• Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J. Am. Coll. Cardiol. 47(1), 76–84 (2006).
   PubMed Web of Science ®Google Scholar
• Chen J, Dharmarajan K, Wang Y, Krumholz HM. National trends in heart failure hospital stay rates, 2001 to 2009. J. Am. Coll. Cardiol. 61(10), 1078–1088 (2013).
   PubMed Web of Science ®Google Scholar
• Jhund PS, Macintyre K, Simpson CR et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 119(4), 515–523 (2009).
   PubMed Web of Science ®Google Scholar
• Mosterd A, Reitsma JB, Grobbee DE. Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic? Heart 87(1), 75–76 (2002).
   PubMed Web of Science ®Google Scholar
• Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur. Heart J. 25(4), 300–307 (2004).
   PubMed Web of Science ®Google Scholar
• Wasywich CA, Gamble GD, Whalley GA, Doughty RN. Understanding changing patterns of survival and hospitalization for heart failure over two decades in New Zealand: utility of 'days alive and out of hospital' from epidemiological data. Eur. J. Heart Fail. 12(5), 462–468 (2010).
   PubMed Web of Science ®Google Scholar
• Hall MJ, Levant S, DeFrances CJ. Hospitalization for Congestive Heart Failure: United States, 2000–2010. NCHS Data Brief 108, 1–8 (2012).
   Google Scholar
• Pang PS, Cleland JG, Teerlink JR et al. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur. Heart J. 29(6), 816–824 (2008).
   PubMed Web of Science ®Google Scholar
• Pang PS, Gheorghiade M, Dihu J et al. Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Trials. Am. Heart J. 161(6), 1067–1072 (2011).
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am. J. Med. 119(12 Suppl. 1), S3–S10 (2006).
   Web of Science ®Google Scholar
• Gheorghiade M, Pang PS. Acute heart failure syndromes. J. Am. Coll. Cardiol. 53(7), 557–573 (2009).
   PubMed Web of Science ®Google Scholar
• Nohria A, Tsang SW, Fang JC et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J. Am. Coll. Cardiol. 41(10), 1797–1804 (2003).
   PubMed Web of Science ®Google Scholar
• Collins S, Storrow AB, Kirk JD, Pang PS, Diercks DB, Gheorghiade M. Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department. Ann. Emerg. Med. 51(1), 45–57 (2008).
   PubMed Web of Science ®Google Scholar
• Zehtabchi S, Brandler ES. Evidence-based emergency medicine/rational clinical examination abstract. Does this patient have congestive heart failure? Ann. Emerg. Med. 51(1), 87–90 (2008).
   PubMedGoogle Scholar
• Yancy CW, Jessup M, Bozkurt B et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. J. Am. Coll. Cardiol. doi:10.1016/j.jacc.2013.05.019 (2013) ( Epub ahead of print).
   Google Scholar
• Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 347(3), 161–167 (2002).
   PubMed Web of Science ®Google Scholar
• Maisel A, Mueller C, Adams K Jr et al. State of the art: Using natriuretic peptide levels in clinical practice. Eur. J. Heart Fail. 10(9), 824–839 (2008).
   PubMed Web of Science ®Google Scholar
• Mueller C, Scholer A, Laule-Kilian K et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N. Engl. J. Med. 350(7), 647–654 (2004).
   PubMed Web of Science ®Google Scholar
• Januzzi JL Jr, Camargo CA, Anwaruddin S et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am. J. Cardiol. 95(8), 948–954 (2005).
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Braunwald E. A proposed model for initial assessment and management of acute heart failure syndromes. JAMA 305(16), 1702–1703 (2011).
   PubMed Web of Science ®Google Scholar
• Nieminen MS, Bohm M, Cowie MR et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur. Heart J. 26(4), 384–416 (2005).
   PubMed Web of Science ®Google Scholar
• Drexler B, Heinisch C, Balmelli C et al. Quantifying cardiac hemodynamic stress and cardiomyocyte damage in ischemic and nonischemic acute heart failure. Circ. Heart Fail. 5(1), 17–24 (2012).
   PubMed Web of Science ®Google Scholar
• Vital FM, Saconato H, Ladeira MT et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema. Cochrane Database Syst. Rev. (3), CD005351 (2008).
   Google Scholar
• Gray A, Goodacre S, Newby DE et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. N. Engl. J. Med. 359(2), 142–151 (2008).
   PubMed Web of Science ®Google Scholar
• Cotter G, Felker GM, Adams KF, Milo-Cotter O, O'Connor CM. The pathophysiology of acute heart failure – is it all about fluid accumulation? Am. Heart J. 155(1), 9–18 (2008).
   PubMed Web of Science ®Google Scholar
• Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload in acute heart failure – re-distribution and other mechanisms beyond fluid accumulation. Eur. J. Heart Fail. 10(2), 165–169 (2008).
   PubMed Web of Science ®Google Scholar
• Silvers SM, Howell JM, Kosowsky JM, Rokos IC, Jagoda AS; American College of Emergency Physicians. Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes. Ann. Emerg. Med. 49(5), 627–669 (2007).
   PubMed Web of Science ®Google Scholar
• O'Connor CM, Starling RC, Hernandez AF et al. Effect of nesiritide in patients with acute decompensated heart failure. N. Engl. J. Med. 365(1), 32–43 (2011).
   PubMed Web of Science ®Google Scholar
• Teerlink JR, Cotter G, Davison BA et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381(9860), 29–39 (2013).
   PubMed Web of Science ®Google Scholar
• Levy P, Compton S, Welch R et al. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. Ann. Emerg. Med. 50(2), 144–152 (2007).
   PubMed Web of Science ®Google Scholar
• Cotter G, Metzkor E, Kaluski E et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 351(9100), 389–393 (1998).
   PubMed Web of Science ®Google Scholar
• Breidthardt T, Noveanu M, Potocki M et al. Impact of a high-dose nitrate strategy on cardiac stress in acute heart failure: a pilot study. J. Intern. Med. 267(3), 322–330 (2010).
   PubMed Web of Science ®Google Scholar
• Sackner-Bernstein J, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure. JAMA 293(15), 1900–1905 (2005).
   PubMed Web of Science ®Google Scholar
• Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111(12), 1487–1491 (2005).
   PubMed Web of Science ®Google Scholar
• Verma SP, Silke B, Reynolds GW, Kelly JG, Richmond A, Taylor SH. Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition. J. Cardiovasc. Pharmacol. 20(2), 274–281 (1992).
   PubMed Web of Science ®Google Scholar
• Vitovec J, Spinar J. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group. Eur. J. Heart Fail. 2(3), 299–304 (2000).
   PubMed Web of Science ®Google Scholar
• Peacock WF CA, Collins S, Fonarow G, Garrison N, Mebezaa A. Clevidipine improves dyspnea in emergency department acute heart failure: a randomized, open label study. Circulation 126, A15606 (2012).
   Web of Science ®Google Scholar
• Felker GM, O'Connor CM, Braunwald E et al.; Heart Failure Clinical Research Network Investigators. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ. Heart Fail. 2(1), 56–62 (2009).
   PubMed Web of Science ®Google Scholar
• Butler J, Forman DE, Abraham WT et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am. Heart J. 147(2), 331–338 (2004).
   PubMed Web of Science ®Google Scholar
• Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100(12), 1311–1315 (1999).
   PubMed Web of Science ®Google Scholar
• Hasselblad V, Gattis Stough W, Shah MR et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur. J. Heart Fail. 9(10), 1064–1069 (2007).
   PubMed Web of Science ®Google Scholar
• Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann. Intern. Med. 103(1), 1–6 (1985).
   PubMed Web of Science ®Google Scholar
• Hill JA, Yancy CW, Abraham WT. Beyond diuretics: management of volume overload in acute heart failure syndromes. Am. J. Med. 119(12 Suppl. 1), S37–S44 (2006).
   PubMed Web of Science ®Google Scholar
• Felker GM, Lee KL, Bull DA et al. Diuretic strategies in patients with acute decompensated heart failure. N. Engl. J. Med. 364(9), 797–805 (2011).
   PubMed Web of Science ®Google Scholar
• Adams JKF, Fonarow GC, Emerman CL et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am. Heart J. 149(2), 209–216 (2005).
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Vaduganathan M, Ambrosy A et al. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail. Rev. 18(2), 107–122 (2013).
   PubMed Web of Science ®Google Scholar
• Abraham WT, Adams KF, Fonarow GC et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J. Am. Coll. Cardiol. 46(1), 57–64 (2005).
   PubMed Web of Science ®Google Scholar
• Felker GM, Benza RL, Chandler AB et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J. Am. Coll. Cardiol. 41, 997–1003 (2003).
   PubMed Web of Science ®Google Scholar
• Metra M, Nodari S, D'Aloia A et al. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J. Am. Coll. Cardiol. 40(7), 1248–1258 (2002).
   PubMed Web of Science ®Google Scholar
• Teerlink JR. A novel approach to improve cardiac performance: cardiac myosin activators. Heart Fail. Rev. 14(4), 289–298 (2009).
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Neumann FJ et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N. Engl. J. Med. 367(14), 1287–1296 (2012).
   PubMed Web of Science ®Google Scholar
• Cheng JM, den Uil CA, Hoeks SE et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur. Heart J. 30(17), 2102–2108 (2009).
   PubMed Web of Science ®Google Scholar
• Piccini JP, Hernandez AF, Zhao X et al. Quality of care for atrial fibrillation among patients hospitalized for heart failure. J. Am. Coll. Cardiol. 54(14), 1280–1289 (2009).
   PubMed Web of Science ®Google Scholar
• Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(7), e257–e354 (2006).
   PubMed Web of Science ®Google Scholar
• Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J. Am. Coll. Cardiol. 48(4), 854–906 (2006).
   PubMed Web of Science ®Google Scholar
• Fonarow GC, Abraham WT, Albert NM et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch. Intern. Med. 168(8), 847–854 (2008).
   PubMedGoogle Scholar
• Shah SJ, Gheorghiade M. Heart failure with preserved ejection fraction: treat now by treating comorbidities. JAMA 300(4), 431–433 (2008).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National Hospital Ambulatory Medical Care Survey: 2009 Emergency Department Summary Tables.
   Google Scholar
• Hugli O, Braun JE, Kim S, Pelletier AJ, Camargo CA Jr. United States emergency department visits for acute decompensated heart failure, 1992 to 2001. Am. J. Cardiol. 96(11), 1537–1542 (2005).
   PubMed Web of Science ®Google Scholar
• Graff L, Orledge J, Radford MJ, Wang Y, Petrillo M, Maag R. Correlation of the Agency for Health Care Policy and Research congestive heart failure admission guideline with mortality: peer review organization voluntary hospital association initiative to decrease events (PROVIDE) for congestive heart failure. Ann. Emerg. Med. 34(4 Pt 1), 429–437 (1999).
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Pang PS. Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality? J. Am. Coll. Cardiol. 53(25), 2349–2352 (2009).
   PubMed Web of Science ®Google Scholar
• Collins SP, Lindsell CJ, Naftilan AJ et al. Low-risk acute heart failure patients: external validation of the Society of Chest Pain Center's recommendations. Crit. Pathw. Cardiol. 8(3), 99–103 (2009).
   PubMedGoogle Scholar
• Collins SP, Storrow AB. Acute heart failure risk stratification: can we define low risk? Heart Fail. Clin. 5(1), 75–83 (2009).
   PubMedGoogle Scholar
• Collins SP, Pang PS, Fonarow GC, Yancy CW, Bonow RO, Gheorghiade M. Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. J. Am. Coll. Cardiol. 61(2), 121–126 (2013).
   PubMed Web of Science ®Google Scholar
• Pang PS, Jesse R, Collins SP, Maisel A. Patients with acute heart failure in the emergency department: do they all need to be admitted? J. Card. Fail. 18(12), 900–903 (2012).
   PubMed Web of Science ®Google Scholar
• Lee DS, Schull MJ, Alter DA et al. Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis. Circ. Heart Fail. 3(2), 228–235 (2010).
   PubMed Web of Science ®Google Scholar
• Kociol RD, Peterson ED, Hammill BG et al. National survey of hospital strategies to reduce heart failure readmissions: findings from the Get With the Guidelines-Heart Failure registry. Circ. Heart Fail. 5(6), 680–687 (2012).
   PubMed Web of Science ®Google Scholar
• Bradley EH, Curry L, Horwitz LI et al. Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study. J. Am. Coll. Cardiol. 60(7), 607–614 (2012).
   PubMed Web of Science ®Google Scholar
• Butler J, Kalogeropoulos A. Hospital strategies to reduce heart failure readmissions: where is the evidence? J. Am. Coll. Cardiol. 60(7), 615–617 (2012).
   PubMed Web of Science ®Google Scholar
• Pang PS, Gheorghiade M. A review of phase II acute heart failure syndromes clinical trials. Heart Fail. Clin. 7(4), 441–450 (2011).
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Trogdon JG, Khavjou OA et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123(8), 933–944 (2011).
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Albert NM, Allen LA et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ. Heart Fail. 6(3), 606–619 (2013).
   PubMed Web of Science ®Google Scholar
• Epstein AM, Jha AK, Orav EJ. The relationship between hospital admission rates and rehospitalizations. N. Engl. J. Med. 365(24), 2287–2295 (2011).
   PubMed Web of Science ®Google Scholar
• Vaduganathan M, Bonow RO, Gheorghiade M. Thirty-day readmissions: the clock is ticking. JAMA 309(4), 345–346 (2013).
   PubMed Web of Science ®Google Scholar
• Joynt KE, Jha AK. Thirty-day readmissions – truth and consequences. N. Engl. J. Med. 366(15), 1366–1369 (2012).
   PubMed Web of Science ®Google Scholar
• Pang PS, Hoffmann U, Shah SJ. Classification of patients with acute heart failure syndromes in the emergency department. Circ. Heart Fail. 5(1), 2–5 (2012).
   PubMed Web of Science ®Google Scholar
• Peacock WF, Braunwald E, Abraham W et al. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. J. Am. Coll. Cardiol. 56(5), 343–351 (2010).
   PubMed Web of Science ®Google Scholar
• Maisel A. Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research. J. Am. Coll. Cardiol. 58(18), 1890–1892 (2011).
   PubMed Web of Science ®Google Scholar
• Boerrigter G, Soergel DG, Violin JD, Lark MW, Burnett JC Jr. TRV120027, a novel beta-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure. Circ. Heart Fail. 5(5), 627–634 (2012).
   PubMed Web of Science ®Google Scholar
• Boerrigter G, Lark MW, Whalen EJ, Soergel DG, Violin JD, Burnett JC Jr. Cardiorenal actions of TRV120027, a novel ss-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure. Circ. Heart Fail. 4(6), 770–778 (2011).
   PubMed Web of Science ®Google Scholar
• Peacock WF 4th, De Marco T, Fonarow GC et al. Cardiac troponin and outcome in acute heart failure. N. Engl. J. Med. 358(20), 2117–2126 (2008).
   PubMed Web of Science ®Google Scholar
• Metra M, Cotter G, Davison BA et al. effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J. Am. Coll. Cardiol. 61(2), 196–206 (2013).
   PubMed Web of Science ®Google Scholar
• Felker GM, Hasselblad V, Tang WH et al. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. Eur. J. Heart Fail. 14(11), 1257–1264 (2012).
   PubMed Web of Science ®Google Scholar
• O'Connor CM, Fiuzat M, Lombardi C et al. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. Circ. Heart Fail. 4(6), 724–732 (2011).
   PubMed Web of Science ®Google Scholar
• Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O'Connor CM, Felker GM. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J. Am. Coll. Cardiol. 56(14), 1071–1078 (2010).
   PubMed Web of Science ®Google Scholar
• Albaghdadi M, Gheorghiade M, Pitt B. Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes. Eur. Heart J. 32(21), 2626–2633 (2011).
   PubMedGoogle Scholar
• Yancy CW. Current approaches to monitoring and management of heart failure. Rev. Cardiovasc. Med. 7( Suppl. 1), S25–S32 (2006).
   Web of Science ®Google Scholar
• O'Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M. Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J. Card. Fail. 11(3), 200–205 (2005).
   PubMed Web of Science ®Google Scholar
• Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition–multimorbidity. JAMA 307(23), 2493–2494 (2012).
   PubMed Web of Science ®Google Scholar
• McNallan S, Singh M, Chamberlain A et al. Frailty and healthcare utilization among patients with heart failure in the community. J. Am. Coll. Cardiol. Heart Fail. 1(2), 135–141 (2013).
   PubMed Web of Science ®Google Scholar
• Allen LA, Hernandez AF, Peterson ED et al. Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ. Heart Fail. 4(3), 293–300 (2011).
   PubMed Web of Science ®Google Scholar
• Chaudhry SI, McAvay G, Chen S et al. Risk factors for hospital admission among older persons with newly diagnosed heart failure: findings from the cardiovascular health study. J. Am. Coll. Cardiol. 61(6), 635–642 (2013).
   PubMed Web of Science ®Google Scholar
• Hernandez AF, Fonarow GC. BNP-guided heart failure therapy in older patients. JAMA 301(20), 2091–2092, author reply 2092–2093 (2009).
   PubMedGoogle Scholar
• Kjekshus J, Apetrei E, Barrios V et al. Rosuvastatin in older patients with systolic heart failure. N. Engl. J. Med. 357(22), 2248–2261 (2007).
   PubMed Web of Science ®Google Scholar
• Konick-McMahan J, Bixby B, McKenna C. Heart failure in older adults. Providing nursing care to improve outcomes. J. Gerontol. Nurs. 29(12), 35–41 (2003).
   PubMedGoogle Scholar
• Naylor MD, Brooten DA, Campbell RL, Maislin G, McCauley KM, Schwartz JS. Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial. J. Am. Geriatr. Soc. 52(5), 675–684 (2004).
   PubMed Web of Science ®Google Scholar
• Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA 291(11), 1358–1367 (2004).
   PubMed Web of Science ®Google Scholar
• Jondeau G, Neuder Y, Eicher JC et al. B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode. Eur. Heart. J. 30(18), 2186–2192 (2009).
   PubMed Web of Science ®Google Scholar
• Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122(3), 265–272 (2010).
   PubMed Web of Science ®Google Scholar